A metabolic network approach for the identification and prioritization of antimicrobial drug targets

Trends in Microbiology

Volumn 20, Issue 3, 2012, Pages 113-123

  Chavali, Arvind K ^a   D'Auria, Kevin M ^a   Hewlett, Erik L ^b   Pearson, Richard D ^b   Papin, Jason A ^a  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BIOMASS; CELL METABOLISM; COMPUTER MODEL; DRUG EFFICACY; DRUG RESEARCH; DRUG TARGETING; ENZYME ACTIVITY; GENOME ANALYSIS; HOST CELL; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; METABOLIC REGULATION; METABOLITE; MICROBIAL GENETICS; NONHUMAN; NUTRIENT AVAILABILITY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REVIEW; STEADY STATE; STOICHIOMETRY; SYSTEMS BIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG DISCOVERY; HUMANS; METABOLIC NETWORKS AND PATHWAYS; SYSTEMS BIOLOGY;

EID: 84857999389     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2011.12.004     Document Type: Review

References (79)

1. Jamshidi N., Palsson B.O. Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst. Biol. 2007, 1:26.
2. Fang X., et al. Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis. BMC Syst. Biol. 2010, 4:160.
3. Segovia-Juarez J.L., et al. Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. J. Theor. Biol. 2004, 231:357-376.
4. Oberhardt M.A., et al. Applications of genome-scale metabolic reconstructions. Mol. Syst. Biol. 2009, 5:320.
5. Thiele I., Palsson B.O. A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat. Protoc. 2010, 5:93-121.
6. Edwards J.S., Palsson B.O. The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and capabilities. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:5528-5533.
7. Reed J.L., et al. An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol. 2003, 4:R54.
8. Edwards J.S., Palsson B.O. Systems properties of the Haemophilus influenzae Rd metabolic genotype. J. Biol. Chem. 1999, 274:17410-17416.
9. Schilling C.H., Palsson B.O. Assessment of the metabolic capabilities of Haemophilus influenzae Rd through a genome-scale pathway analysis. J. Theor. Biol. 2000, 203:249-283.
10. Henry C.S., et al. High-throughput generation, optimization and analysis of genome-scale metabolic models. Nat. Biotechnol. 2010, 28:977-982.
11. Durot M., et al. Genome-scale models of bacterial metabolism: reconstruction and applications. FEMS Microbiol. Rev. 2009, 33:164-190.
12. Lee J.M., et al. Flux balance analysis in the era of metabolomics. Brief Bioinform. 2006, 7:140-150.
13. Gianchandani E.P., et al. The application of flux balance analysis in systems biology. Wiley Interdiscip. Rev. Syst. Biol. Med. 2010, 2:372-382.
14. Price N.D., et al. Genome-scale models of microbial cells: evaluating the consequences of constraints. Nat. Rev. Microbiol. 2004, 2:886-897.
15. Feist A.M., Palsson B.O. The biomass objective function. Curr. Opin. Microbiol. 2010, 13:344-349.
16. Varma A., Palsson B.O. Metabolic capabilities of Escherichia coli. 1. Synthesis of biosynthetic precursors and cofactors. J. Theor. Biol. 1993, 165:477-502.
17. Mazumdar V., et al. Metabolic network model of a human oral pathogen. J. Bacteriol. 2009, 191:74-90.
18. Chavali A.K., et al. Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol. Syst. Biol. 2008, 4:177.
19. Beste D.J., et al. GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism. Genome Biol. 2007, 8:R89.
20. Edwards J.S., Palsson B.O. Robustness analysis of the Escherichia coli metabolic network. Biotechnol. Prog. 2000, 16:927-939.
21. Raghunathan A., et al. Systems approach to investigating host-pathogen interactions in infections with the biothreat agent Francisella. Constraints-based model of Francisella tularensis. BMC Syst. Biol. 2010, 4:118.
22. Mahadevan R., Schilling C.H. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab. Eng. 2003, 5:264-276.
23. Dobson P.D., et al. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discov. Today 2009, 14:31-40.
24. Kim H.U., et al. Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. Mol. Biosyst. 2010, 6:339-348.
25. Kim H.U., et al. Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol. Syst. Biol. 2011, 7:460.
26. Yildirim M.A., et al. Drug-target network. Nat. Biotechnol. 2007, 25:1119-1126.
27. Becker S.A., et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat. Protoc. 2007, 2:727-738.
28. Papin J.A., et al. Hierarchical thinking in network biology: the unbiased modularization of biochemical networks. Trends Biochem. Sci. 2004, 29:641-647.
29. Xi Y., et al. Comparative study of computational methods to detect the correlated reaction sets in biochemical networks. Brief Bioinform. 2010, 12:132-150.
30. Raman K., et al. targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst. Biol. 2008, 2:109.
31. Shen Y., et al. Blueprint for antimicrobial hit discovery targeting metabolic networks. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1082-1087.
32. Hopkins A.L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 2008, 4:682-690.
33. Chong C.R., Sullivan D.J. New uses for old drugs. Nature 2007, 448:645-646.
34. McConville M.J., et al. Living in a phagolysosome; metabolism of Leishmania amastigotes. Trends Parasitol. 2007, 23:368-375.
35. Sauer J.D., et al. The phagosomal transporter A couples threonine acquisition to differentiation and replication of Legionella pneumophila in macrophages. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9924-9929.
36. Brown S.A., et al. Revisiting the host as a growth medium. Nat. Rev. Microbiol. 2008, 6:657-666.
37. Huthmacher C., et al. Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis. BMC Syst. Biol. 2010, 4:120.
38. Shlomi T., et al. Network-based prediction of human tissue-specific metabolism. Nat. Biotechnol. 2008, 26:1003-1010.
39. Becker S.A., Palsson B.O. Context-specific metabolic networks are consistent with experiments. PLoS Comput. Biol. 2008, 4:e1000082.
40. Jensen P.A., Papin J.A. Functional integration of a metabolic network model and expression data without arbitrary thresholding. Bioinformatics 2011, 27:541-547.
41. Schwegmann A., Brombacher F. Host-directed drug targeting of factors hijacked by pathogens. Sci. Signal. 2008, 1:re8.
42. Sakamoto H., et al. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nat. Chem. Biol. 2005, 1:333-337.
43. Handley S.A., et al. Histamine signaling through the H(2) receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9268-9273.
44. Hossain H., et al. Host gene expression profiling in pathogen-host interactions. Curr. Opin. Immunol. 2006, 18:422-429.
45. Diamond D.L., et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 2010, 6:e1000719.
46. Carette J.E., et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science 2009, 326:1231-1235.
47. Oberhardt M.A., et al. Genome-scale metabolic network analysis of the opportunistic pathogen Pseudomonas aeruginosa PAO1. J. Bacteriol. 2008, 190:2790-2803.
48. Puchalka J., et al. Genome-scale reconstruction and analysis of the Pseudomonas putida KT2440 metabolic network facilitates applications in biotechnology. PLoS Comput. Biol. 2008, 4:e1000210.
49. Oberhardt M.A., et al. Reconciliation of genome-scale metabolic reconstructions for comparative systems analysis. PLoS Comput. Biol. 2011, 7:e1001116.
50. Stolyar S., et al. Metabolic modeling of a mutualistic microbial community. Mol. Syst. Biol. 2007, 3:92.
51. Oberhardt M.A., et al. Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection. J. Bacteriol. 2010, 192:5534-5548.
52. Overbeek R., et al. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 2005, 33:5691-5702.
53. Aziz R.K., et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 2008, 9:75.
54. Langridge G.C., et al. Simultaneous assay of every Salmonella Typhi gene using one million transposon mutants. Genome Res. 2009, 19:2308-2316.
55. Fang K., et al. Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale reconstruction. BMC Syst. Biol. 2011, 5:83.
56. Thiele I., et al. Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants. J. Bacteriol. 2005, 187:5818-5830.
57. Schilling C.H., et al. Genome-scale metabolic model of Helicobacter pylori 26695. J. Bacteriol. 2002, 184:4582-4593.
58. Liao Y.C., et al. An experimentally validated genome-scale metabolic reconstruction of Klebsiella pneumoniae MGH 78578, iYL1228. J. Bacteriol. 2011, 193:1710-1717.
59. Baart G.J., et al. Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes. Genome Biol. 2007, 8:R136.
60. AbuOun M., et al. Genome scale reconstruction of a Salmonella metabolic model: comparison of similarity and differences with a commensal Escherichia coli strain. J. Biol. Chem. 2009, 284:29480-29488.
61. Thiele I., et al. A community effort towards a knowledge-base and mathematical model of the human pathogen Salmonella Typhimurium LT2. BMC Syst. Biol. 2011, 5:8.
62. Raghunathan A., et al. Constraint-based analysis of metabolic capacity of Salmonella Typhimurium during host-pathogen interaction. BMC Syst. Biol. 2009, 3:38.
63. Lee D.S., et al. Comparative genome-scale metabolic reconstruction and flux balance analysis of multiple Staphylococcus aureus genomes identify novel antimicrobial drug targets. J. Bacteriol. 2009, 191:4015-4024.
64. Heinemann M., et al. In silico genome-scale reconstruction and validation of the Staphylococcus aureus metabolic network. Biotechnol. Bioeng. 2005, 92:850-864.
65. Becker S.A., Palsson B.O. Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: an initial draft to the two-dimensional annotation. BMC Microbiol. 2005, 5:8.
66. Navid A., Almaas E. Genome-scale reconstruction of the metabolic network in Yersinia pestis, strain 91001. Mol. Biosyst. 2009, 5:368-375.
67. Vanee N., et al. A genome-scale metabolic model of Cryptosporidium hominis. Chem. Biodivers. 2010, 7:1026-1039.
68. Plata G., et al. Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network. Mol. Syst. Biol. 2010, 6:408.
69. Roberts S.B., et al. Proteomic and network analysis characterize stage-specific metabolism in Trypanosoma cruzi. BMC Syst. Biol. 2009, 3:52.
70. Duarte N.C., et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1777-1782.
71. Segre D., et al. Analysis of optimality in natural and perturbed metabolic networks. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15112-15117.
72. Feist A.M., et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol. Syst. Biol. 2007, 3:121.
73. Hsiao T.L., et al. Automatic policing of biochemical annotations using genomic correlations. Nat. Chem. Biol. 2010, 6:34-40.
74. Szappanos B., et al. An integrated approach to characterize genetic interaction networks in yeast metabolism. Nat. Genet. 2011, 43:656-662.
75. Boyle N.R., Morgan J.A. Flux balance analysis of primary metabolism in Chlamydomonas reinhardtii. BMC Syst. Biol. 2009, 3:4.
76. 13C-metabolic flux analysis and flux balance analysis for understanding metabolic adaptation to anaerobiosis in E. coli. Metab. Eng. 2011, 13:38-48.
77. 13C-flux analysis reveals mechanistic principles of metabolic network robustness to null mutations in yeast. Genome Biol. 2005, 6:R49.
78. Varma A., Palsson B.O. Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110. Appl. Environ. Microbiol. 1994, 60:3724-3731.
79. Forster J., et al. Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res. 2003, 13:244-253.